Focus on Pathways: Historical Perspective and Current Considerations in Hairy Cell Leukemia

Despite the significant progress that has been made regarding the incidence, risk factors, and symptoms of hairy cell leukemia, diagnosis remains a challenge, due in part to the low incidence of the disease.

Martin S. Tallman, MD, discusses the biology, presentation, and available therapeutic options in hairy cell leukemia.

The pathogenesis, diagnostic criteria, staging, and prognosis of hairy cell leukemia, an uncommon indolent B-cell lymphoid neoplasm, is examined.